Encompass Health (NYSE:EHC) Given New $120.00 Price Target at KeyCorp

Encompass Health (NYSE:EHC) had its price objective hoisted by KeyCorp from $117.00 to $120.00 in a report released on Monday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

EHC has been the subject of a number of other reports. Barclays upped their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday. Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. StockNews.com lowered Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research note on Friday. Finally, Royal Bank of Canada upped their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $107.67.

Encompass Health Price Performance

EHC stock opened at $98.66 on Monday. The company has a market cap of $9.94 billion, a PE ratio of 22.12, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a 50-day moving average price of $96.20 and a two-hundred day moving average price of $95.35. Encompass Health has a 12-month low of $72.38 and a 12-month high of $104.55.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. As a group, research analysts predict that Encompass Health will post 4.76 EPS for the current year.

Institutional Investors Weigh In On Encompass Health

Hedge funds have recently added to or reduced their stakes in the stock. TD Private Client Wealth LLC increased its stake in shares of Encompass Health by 2,870.0% during the third quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock valued at $709,000 after acquiring an additional 7,089 shares during the period. Los Angeles Capital Management LLC lifted its stake in Encompass Health by 532.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after acquiring an additional 42,338 shares in the last quarter. Pathstone Holdings LLC boosted its holdings in shares of Encompass Health by 54.5% during the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after purchasing an additional 7,412 shares during the period. Meeder Asset Management Inc. increased its stake in Encompass Health by 43.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock valued at $6,417,000 after buying an additional 20,242 shares during the period. Finally, Geode Capital Management LLC lifted its position in Encompass Health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after buying an additional 20,547 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.